FDA authorizes Quest Diagnostics' proprietary monkeypox test

Quest Diagnostics, a leading provider of diagnostic information services, has announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the Monkeypox virus. 

Related Keywords

United States , Jayg Wohlgemuth , , Centers For Disease , Human Services , Drug Administration , York Department Of Health , Department Of Health , Lab Alert , Quest Diagnostics , Industry News , Quest Diagnostic , Senior Vice President , Chief Medical Officer , West African , Quest Monkeypox , San Juan Capistrano , New York , Disease Control , Federal Food , Cosmetic Act , Fda Authorizes Quest Diagnostics Proprietary Monkeypox Test For Emergency Use , Virus , Pest , Cr , Fda , Ua ,